T2DM is characterized by changes in beta-cell mass, decreased insulin secretion, and elevation in intestinal glucose absorption, upsurge in glucagon secretion, increase in insulin breakdown, insulin resistance, and increased levels of catecholamines. This evidence concerns the gene INS and type 2 diabetes mellitus.